Sofya Pintova, MD
- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Dr. Sofya Pintova is an Assistant Professor in the Department of Medicine, Division of Hematology and Medical Oncology. Dr. Pintova's interests include treatment and the development of new therapies for gastrointestinal malignancies including colorectal, pancreatobiliary, esophageal, gastric and neuroendocrine tumors.
American Board of Internal Medicine
- Anal Cancer
- Appendix Cancer
- Carcinoid Tumors
- Colon Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric (Stomach) Cancer
- Gastrointestinal Cancers
- Hepatocellular Carcinoma
- Liver Cancer
- Neuroendocrine Tumors
- Pancreatic Cancer
- Rectal Cancer
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Unknown Primary Tumors
MD, SUNY Upstate Medical Center
MD, SUNY Upstate Medical University
Einstein School of Medicine/Motefiore Medical Center
Mount Sinai School of Medicine
Residency, Internal Medicine, Montefiore Medical Center /Albert Einstein College of Medicine
Fellowship, Hematology/Oncology, Mount Sinai Hospital
Dr. Pintova's research focuses on novel clinical therapeutics and development of communication skills for medical oncologists caring for advanced cancer patients.
- A Multi-Institutional, Single Arm, Two-Stage Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients with Advanced or Metastatic Cholangiocarcinoma
This is a phase II study, which means that the goal of this study is to find out what effects, good and/or bad, the drug combination of Nab-Paclitaxel (also known as Abraxane) and Gemcitabine (also known as Gemzar) has on you and your cancer. This study is designed to ex...
Holcombe RF. Genistein: Mechanisms of Action in Colorectal Cancer. Future Medicine 2013.
Pintova S, Sidhu H, Friedlander PA, Holcombe RF. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma research 2013 Dec; 23(6).
Pintova S, Cohen HW, Billett HH. Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum?. PloS one 2013; 8(5).
Pintova S, Bhardwaj AS, Aledort LM. IVIG--a hemolytic culprit. The New England journal of medicine 2012 Sep; 367(10).